Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure
about
Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple IntegrinsRadiolabeled cyclic RGD peptides as radiotracers for tumor imagingChallenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies.Risks of proteinuria associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a systematic review and meta-analysisAn open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors.Spectrophotometric and molecular modelling studies on in vitro interaction of tyrosine kinase inhibitor linifanib with bovine serum albuminMonitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2.Integrin α(v)β₃-targeted radiotracer (99m)Tc-3P-RGD₂ useful for noninvasive monitoring of breast tumor response to antiangiogenic linifanib therapy but not anti-integrin α(v)β₃ RGD₂ therapy.Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after disease progression with other targeted therapiesProgress of molecular targeted therapies for advanced renal cell carcinoma.New agents in renal cell carcinoma.Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art.Linifanib: current status and future potential in cancer therapy.Results of a phase 1, randomized study evaluating the effects of food and diurnal variation on the pharmacokinetics of linifanib.Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumorsSimple, sensitive and rapid determination of linifanib (ABT-869), a novel tyrosine kinase inhibitor in rat plasma by UHPLC-MS/MS.Integrin αVβ3-targeted SPECT/CT for the assessment of Bevacizumab therapy in orthotopic lung cancer xenografts.OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers
P2860
Q26801806-F973693E-008C-4AA0-90D0-DE15B57C229CQ28072021-355953F7-659C-4C89-B794-621F891D2ADFQ34627828-47266540-DDC5-4C5F-8AE7-4FD4FF9577AFQ35118673-D76F0782-0309-4E1E-98C5-E8F5C28A92E4Q35996229-650E5D28-5F32-4E2E-AE2E-A97B512021D8Q36349729-3D5AD9F3-A1B5-442D-A139-2DB9D7890A45Q37027027-1C9B8ADE-4ADA-43F7-AEA9-0F6E5DA6BC83Q37344824-A2E829C9-5C65-4794-B07C-70A49E9DB99CQ37438970-E7399321-FF66-42C2-BB2F-A79E865E3A47Q38149133-3535E737-3999-4A82-ACAA-CFE027B72102Q38163483-9157A008-3667-4AEC-93AC-103DAB912DD3Q38264616-B489FD1D-0098-47B2-8E82-7F29E1D30A2DQ38455525-07D139AA-85F2-4A29-ADEF-053347419675Q39196166-39C33538-35B9-4C80-9DDE-10642EEF65CBQ41816476-E064A9F6-F761-4FA9-8177-D7DCEBA9A577Q41972452-7FE13EC7-23BD-4526-8CAD-2B69DA3E7A7BQ55265366-A94580A5-9203-4DD5-8786-08EEFDF523B9Q59123158-AFB56A26-2815-421C-BE3F-B1989C12361F
P2860
Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phase 2 trial of linifanib (AB ...... cancer after sunitinib failure
@ast
Phase 2 trial of linifanib (AB ...... cancer after sunitinib failure
@en
Phase 2 trial of linifanib
@nl
type
label
Phase 2 trial of linifanib (AB ...... cancer after sunitinib failure
@ast
Phase 2 trial of linifanib (AB ...... cancer after sunitinib failure
@en
Phase 2 trial of linifanib
@nl
prefLabel
Phase 2 trial of linifanib (AB ...... cancer after sunitinib failure
@ast
Phase 2 trial of linifanib (AB ...... cancer after sunitinib failure
@en
Phase 2 trial of linifanib
@nl
P2093
P2860
P1476
Phase 2 trial of linifanib (AB ...... cancer after sunitinib failure
@en
P2093
Andrew Coates
Christian K Kollmannsberger
Daniel Cho
David J Perry
Dawn M Carlson
Edwin M Posadas
Frank A Scappaticci
Jiang Qian
Jihong Chen
Justin L Ricker
P2860
P304
P356
10.1016/J.EJCA.2011.09.002
P577
2011-11-10T00:00:00Z